Atea Pharmaceuticals, Inc. (AVIR) stock
AVIRNasdaqPharmaceutical PreparationsFiscal year ends December 31
$4.30+0.09 (+2.14%)
Close on Nov 13, 2026Market cap $344.88MP/E –Yield –
Atea Pharmaceuticals enterprise value
Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.
Atea Pharmaceuticals's enterprise value was $119.00M on Nov 11, 2026, against -$87.12M a year earlier. Over the last 5 years it ranged from -$374.36M to $209.63M, with a median of -$199.85M.
Enterprise Value at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | $119.00M | – |
| 2025 | Dec 31, 2025 | -$50.40M | – |
| 2024 | Dec 31, 2024 | -$199.85M | – |
| 2023 | Dec 29, 2023 | -$340.62M | – |
| 2022 | Dec 30, 2022 | -$264.36M | – |
| 2021 | Dec 31, 2021 | -$97.22M | -130.7% |
| 2020 | Dec 31, 2020 | $317.01M | – |
See a number that looks wrong?